Stonepine Capital Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-5,515
| Closed | -$323K | – | 21 |
|
|
2020
Q1 | $323K | Sell |
5,515
-20,921
| -79% | -$1.23M | 0.34% | 26 |
|
|
2019
Q4 | $3.34M | Sell |
26,436
-5,732
| -18% | -$724K | 2.33% | 13 |
|
|
2019
Q3 | $3.85M | Buy |
32,168
+16,693
| +108% | +$2M | 3.73% | 11 |
|
|
2019
Q2 | $4.62M | Sell |
15,475
-279
| -2% | -$83.4K | 3.18% | 12 |
|
|
2019
Q1 | $7.09M | Buy |
15,754
+888
| +6% | +$400K | 4.08% | 7 |
|
|
2018
Q4 | $6.8M | Buy |
14,866
+11,890
| +400% | +$5.44M | 5.97% | 7 |
|
|
2018
Q3 | $2.71M | Sell |
2,976
-6,408
| -68% | -$5.82M | 1.58% | 19 |
|
|
2018
Q2 | $5.51M | Buy |
+9,384
| New | +$5.51M | 3.35% | 11 |
|